CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project investigates non-alcoholic fatty liver disease by examining the role of immune cells in the liver. It aims to understand how these cells contribute to disease progression, with the goal of developing targeted therapies for this growing health issue.
Non-alcoholic fatty liver disease (NAFLD) results from accumulation of excessive fat in the liver.
It encompasses simple steatosis (fatty liver) progressing through non-alcoholic steatohepatitis (NASH), cirrhosis and hepatocellular carcinoma.
It is the most common cause of chronic liver disease in western countries and is predicted to be the main cause of liver transplantation by 2030.
As such NAFLD represents a significant clinical burden for which to date, there is no effective treatment.
Mult…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
